SCHEMBL30133446

SCHEMBL30133446

CNc1nc(Cl)cc2ncccc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 8/20 0.55
CYP1A2 P05177 4/20 0.44
CYP3A4 P08684 3/20 0.44
CYP2D6 P10635 3/20 0.44
CYP2C19 P33261 3/20 0.44
HSD17B10 Q99714 3/20 0.44
CYP2C9 P11712 2/20 0.44
MAPK1 P28482 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
NR4A2 P43354 2/20 0.44
CLK4 Q9HAZ1 4/20 0.42
KDM4E B2RXH2 2/20 0.41
LMNA P02545 1/20 0.41
CDC7 O00311 2/20 0.40
DAPK3 O43293 2/20 0.40
PRKD3 O94806 2/20 0.40
MAP4K4 O95819 2/20 0.40
PAK4 O96013 2/20 0.40
PIM1 P11309 2/20 0.40
PRKACA P17612 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26130603 1.00 SYK (0.55) SYKCYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL24996518 0.81 SYK (0.56) SYKCYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL15233158 0.81 SYK (0.56) SYKCYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL10266502 0.78 SYK (0.52) SYKCYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL2588073 0.77 NR4A2 (0.50) CYP1A2CYP3A4CYP2C19TDP1NR4A2
SCHEMBL30168960 0.75 HTR3A (0.50) SYKCYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL23861062 0.75 HTR3A (0.50) SYKCYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL21574347 0.75 TYK2 (0.40) SYKMAPK1NR4A2CLK4CDC7
SCHEMBL12526131 0.74 YTHDC1 (0.37) SYKLMNALRRK2
SCHEMBL31329846 0.74 NR4A2 (0.56) SYKCYP3A4HSD17B10NR4A2CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115605466-B Substituted oxoisoindoline compounds for the treatment of cancer 百时美施贵宝公司 2024-11-01 CN disclosed
CN-115605466-A Substituted oxoisoindoline compounds for the treatment of cancer 百时美施贵宝公司(US) 2023-01-13 CN disclosed